Ariel Investments, an investment management company, released its "Ariel Focus Fund" fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Ariel Focus Fund delivered mixed results in the fourth quarter of 2025, declining -0.50% and underperforming both the S&P 500 and Russell 1000 Value indices, which gained +2.66% and +3.81%, respectively, although the fund outperformed both benchmarks over the full year with a +20.97% return. The quarter took place in a resilient U.S. market en ...

Quick Read Johnson & Johnson (JNJ) raised its quarterly dividend from $1.24 to $1.30 per share (5% increase) and extended its consecutive dividend hike streak to 63 years, yielding 2.14% annually with a sustainable 46.7% payout ratio and $19.7 billion in free cash flow. Pfizer (PFE) carries payout ratio risk at 118.6% despite higher yield, while Merck (MRK) lacks Johnson & Johnson’s breadth and reliability track record. Johnson & Johnson’s diversified portfolio of medicines, medical devices, and consume ...

Here's Why You Don't Bet Against This Dividend King - 24/7 Wall St. S&P 5006,437.70 +1.39% Dow Jones45,713.20 +0.99% Nasdaq 10023,324.80 +1.61% Russell 20002,453.53 +1.64% FTSE 10010,172.40 +0.90% Nikkei 22551,667.30 +1.25% Stock Market Live March 31, 2026: S&P 500 (SPY) Pops on News Trump Could End War Investing Here's Why You Don't Bet Against This Dividend King By Rich DupreyPublished Mar 31, 11:30AM EDT Quick Read Johnson & Johnson (JNJ) raised its quarterly dividend from $1.24 to $1.30 per share (5% ...

Quick Read Apple (AAPL), Microsoft (MSFT), and Johnson & Johnson (JNJ) are trading at attractive valuations despite posting strong revenue growth (16%, 17%, and 9% respectively in their latest quarters), with Microsoft’s forward P/E down sharply to 22.26x and J&J yielding 2.14%. The CNN Fear & Greed Index at 13 signals extreme fear has only occurred on 3.4% of trading days since 2011, creating a historically opportune moment for investors to deploy capital into quality names rather than panic-selling al ...

Extreme Fear is Gripping the Market, This Is the Smart Move Most Investors Miss - 24/7 Wall St. Quick Read S&P 5006,416.40 +1.06% Dow Jones45,734.20 +1.04% Nasdaq 10023,210.80 +1.11% Russell 20002,446.83 +1.36% FTSE 10010,222.70 +1.40% Nikkei 22551,627.30 +1.18% Investing Extreme Fear is Gripping the Market, This Is the Smart Move Most Investors Miss By Rich DupreyPublished Mar 31, 8:09AM EDT Apple (AAPL), Microsoft (MSFT), and Johnson & Johnson (JNJ) are trading at attractive valuations despite posting ...

For Immediate ReleasesChicago, IL – March 31, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include  Duke Energy Corp. (DUK) , Entergy Corp. (ETR) , Constellation Brands Inc. (STZ) , The Coca-Cola Co. (KO) and Johnson & Johnson (JNJ) .Here are highlights from Tuesday’s Analyst Blog:5 Defensive Stocks to Buy Amid Market' ...

2026 年 3 月 31 日 证券研究报告 估值方面，截至 2026 年 3 月 27 日，医药生物行业 PE（TTM 整体法， 剔除负值）为 29.30x（上期末 30.34x），估值下行，低于均值。医药 生物申万三级行业 PE（TTM 整体法，剔除负值）前三的行业分别为 疫苗（52.48x）、化学制剂（39.95x）、医院（38.35x），中位数为 31.21x，医药流通（13.52x）估值最低。 XXXX@gwgsc.com 重要行业资讯： ◆NMPA：开展医疗器械临床创新成果转化"春雨行动" 医药生物行业双周报 2026 年第 6 期总第 155 期 2026 年 AACR 年会即将举行 创新药板块迎来重要数据催化窗口 行业回顾 评级变动 维持评级 本报告期医药生物行业指数跌幅为 1.26%，在申万 31 个一级行业中 位居第 4，跑赢沪深 300 指数（-3.57%）。从子行业来看，医疗研发 外包、化学制剂涨幅居前，涨幅分别为 2.78%、1.36%；医院、血液 制品跌幅居前，跌幅分别为 8.42%、6.69%。 行业走势： ◆强生：口服 IL-23R 拮抗剂"Icotrokinra"获美国 FD ...

2026 年 3 月 31 日 证券研究报告 医药生物行业双周报 2026 年第 6 期总第 155 期 2026 年 AACR 年会即将举行 创新药板块迎来重要数据催化窗口 行业回顾 评级变动 维持评级 ◆诺华：拟在华投资超 33 亿元人民币 投资建议： 1/24 近期，医药生物板块催化因素持续累积，药械创新仍是当前的核心主 线。一方面，国内政策端继续释放积极信号，NMPA 将在全国范围内 组织实施为期三年的"医疗器械临床创新成果转化"春雨行动"，进 一步强化对创新器械成果转化和产业化落地的支持；另一方面，海外 公司地址：北京市丰台区凤凰嘴街 2 号院 1 号楼中国长城资产大厦 16 层 分析师 胡晨曦 本报告期医药生物行业指数跌幅为 1.26%，在申万 31 个一级行业中 位居第 4，跑赢沪深 300 指数（-3.57%）。从子行业来看，医疗研发 外包、化学制剂涨幅居前，涨幅分别为 2.78%、1.36%；医院、血液 制品跌幅居前，跌幅分别为 8.42%、6.69%。 行业走势： 估值方面，截至 2026 年 3 月 27 日，医药生物行业 PE（TTM 整体法， 剔除负值）为 29.30x（上期末 30 ...

As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles per week on such ideas.We have helped our members not only to beat S&P 500 but also avoid heavy drawdowns despite the extreme volatilities in BOTH the equity AND bond market.Join for a trial and see if our proven method can help you too. ...

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield ...